Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community

doi:10.1503/cmaj.060919

Comment

. 2006 Sep 26;175(7):757.

doi: 10.1503/cmaj.060919.

Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community

Richard Cunningham¹

Affiliations

PMID: 17001056
PMCID: PMC1569916
DOI: 10.1503/cmaj.060919

Comment

Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community

Richard Cunningham. CMAJ. 2006.

. 2006 Sep 26;175(7):757.

doi: 10.1503/cmaj.060919.

Author

Richard Cunningham¹

Affiliation

¹ Department of Microbiology, Derriford Hospital, Plymouth, PL6 8DH, UK.

PMID: 17001056
PMCID: PMC1569916
DOI: 10.1503/cmaj.060919

No abstract available

PubMed Disclaimer

Comment on

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
Dial S, Delaney JA, Schneider V, Suissa S. Dial S, et al. CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284. CMAJ. 2006. PMID: 17001054 Free PMC article.

Cited by

Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
Oshima T, Wu L, Li M, Fukui H, Watari J, Miwa H. Oshima T, et al. J Gastroenterol. 2018 Jan;53(1):84-94. doi: 10.1007/s00535-017-1369-3. Epub 2017 Jul 25. J Gastroenterol. 2018. PMID: 28744822
Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
Khanna S, Aronson SL, Kammer PP, Baddour LM, Pardi DS. Khanna S, et al. Mayo Clin Proc. 2012 Jul;87(7):636-42. doi: 10.1016/j.mayocp.2011.12.021. Mayo Clin Proc. 2012. PMID: 22766083 Free PMC article.

References

1. Archibald LK, Banerjee SH, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987–2001. J Infect Dis 2004;189:1585-9. - PubMed
1. Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171(5):466-72. - PMC - PubMed
1. Health Protection Agency. Reports of Clostridium difficile isolated from faecal specimens under the voluntary reporting scheme: England, Wales, and Northern Ireland 1990–2004. London: The Agency. Available: www.hpa.org.uk/infections/topics_az/clostridium_difficile/vol_data.htm (accessed 2006 Aug 17).
1. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9. - PubMed
1. Pépin J, Saheb N, Coulombe M, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254-60. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Archibald LK, Banerjee SH, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987–2001. J Infect Dis 2004;189:1585-9. - PubMed

[2] Archibald LK, Banerjee SH, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987–2001. J Infect Dis 2004;189:1585-9. - PubMed

[3] Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171(5):466-72. - PMC - PubMed

[4] Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171(5):466-72. - PMC - PubMed

[5] Health Protection Agency. Reports of Clostridium difficile isolated from faecal specimens under the voluntary reporting scheme: England, Wales, and Northern Ireland 1990–2004. London: The Agency. Available: www.hpa.org.uk/infections/topics_az/clostridium_difficile/vol_data.htm (accessed 2006 Aug 17).

[6] Health Protection Agency. Reports of Clostridium difficile isolated from faecal specimens under the voluntary reporting scheme: England, Wales, and Northern Ireland 1990–2004. London: The Agency. Available: www.hpa.org.uk/infections/topics_az/clostridium_difficile/vol_data.htm (accessed 2006 Aug 17).

[7] Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9. - PubMed

[8] Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9. - PubMed

[9] Pépin J, Saheb N, Coulombe M, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254-60. - PubMed

[10] Pépin J, Saheb N, Coulombe M, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254-60. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community

Affiliation

Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical